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Innovations in stent technology and technological advances in endoscopic ultrasonography have led to rapid expansion of their 
use in the field of gastrointestinal diseases. In particular, endoscopic ultrasonography-guided metal stent insertion has been used 
for the management of pancreatic fluid collection, bile duct drainage, gallbladder decompression, and gastric bypass. Endoscopic 
ultrasonography-guided drainage of intra-abdominal fluid collections using a plastic or metal stent is well established. Because of the 
various limitations—such as stent migration, injury and bleeding in the lumen—recently developed, fully covered self-expanding metal 
stents or lumen-apposing metal stents have been introduced for those fluids management. This article reviews the recent literature on 
newly developed endoscopic ultrasonography-guided metal stents and the efficacy thereof. Clin Endosc  2016;49:131-138
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INTRODUCTION
The use of metal stents in the gastrointestinal tract is one 
of the most influential developments in the interventional 
endoscopy. The first clinical application of a metal stent in 
a non-vascular organ was on the tracheobronchial tree by 
Wallace et al.1 Metal stent technology has evolved rapidly over 
the past decade. Recent technological developments in inter-
ventional endoscopic ultrasonography (EUS) and metal stents 
have facilitated EUS-guided procedures using metal stents in 
various gastrointestinal conditions.
Using linear-array echoendoscopes, a needle can be ad-
vanced into the biliary or pancreatic duct under real-time 
ultrasonographic guidance without the risk of injury to the 
intervening vessel. Because the common bile duct and the 
pancreatic duct are near the transducer of the EUS probe, 
both can be visualized without difficulty, and real-time 
puncture can be done easily, thus providing ductal drainage 
using endoscopic retrograde cholangiopancreatography (ER-
CP)-based techniques.2,3 Over the past decades, the availability 
of the linear-array echoendoscope has led to the develop-
ment of multiple EUS-related endoscopic techniques, such as 
pancreatic fluid collection (PFC) drainage, pancreaticogas-
trostomy, EUS-guided antegrade cholangiography and hepa-
ticogastrostomy (HGS), and choledochogastrostomy.4 In the 
early 2000s, the availability of a large-channel echoendoscope 
induced the first reported case of EUS-guided transgastric 
(EUS-HGS) or transduodenal (choledochoduodenostomy, 
EUS-CDS) biliary drainage using stents by Giovannini et al.5,6 
EUS has since evolved continuously from a only diagnostic 
imaging method to an invasive therapeutic procedure. We 
will review new EUS-guided metal stents and future develop-
ments in gastrointestinal diseases and other fields.
LITERATURE REVIEW METHODOLOGY
On November 15, 2015, a PubMed search using the EUS in 
combination with words related to metal stents, such as “metal 
stent” and “therapeutic EUS,” was done. Next, the inclusion 
Received: March 3, 2016    Accepted: March 5, 2016
Correspondence: Moon Jae Chung
Division of Gastroenterology, Department of Internal Medicine, Yonsei Universi-
ty College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-1981, Fax: +82-2-393-6884, E-mail: MJCHUNG@yuhs.ac
cc  This is an Open Access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
132   
criteria were (1) original research articles (randomized con-
trolled trials, prospective and retrospective studies), systemic 
reviews, and case series; (2) case number ≥20; and (3) En-
glish-language publications (Fig. 1).
The publications and their references were reviewed man-
ually. References to proper studies and review articles were 
searched manually to survey additional related studies. The 
bibliographies of the review articles were scrutinized to iden-
tify other references that might have been missed in the initial 
search. Finally, the two authors of this article jointly reviewed 
each published paper, and all relevant information was ex-
tracted.
PANCREATIC FLUID COLLECTION
PFCs include peri-PFCs, pancreatic pseudocysts, acute ne-
crotic collections, and walled-off pancreatic necrosis.7,8 PFCs 
generally require drainage when they cause symptoms such 
as pain, gastric outlet obstruction (GOO), and/or bile duct 
obstruction, or if they are infected.9 The management of PFCs 
has traditionally been surgical, but surgery may be associated 
with relatively higher rates of complications and mortality.10 
With more recent technological advances and experience, en-
doscopic drainage is widely accepted and has replaced surgery 
as the first-line therapy for PFC drainage, as it is less invasive 
and has a shorter recovery time, lower cost, and lower compli-
cation rates.11
EUS guided-endoscopic transmural drainage of PFCs with 
plastic or metal stents has become a widely accepted treat-
ment modality. Previous studies have reported success rates 
comparable to those of percutaneous and surgical interven-
tions, with significant advantages in terms of invasiveness, 
morbidity, length of hospital stay, and cost.12 The procedure 
is preferably performed under EUS guidance, which allows 
access to non-bulging lesions, avoidance of major vessels, and 
accurate assessment of PFC content, which is critical for the 
selection of the number and type of stent to be placed. The 
clinical success rate of EUS-guided PFCs drainage is directly 
related to the necrotic content of PFCs, which increases the 
risk of occlusion of the stents typically used for this type of 
drainage procedure. Historically, double-pigtail plastic stents 
have been the mainstay of therapy. However, because of their 
small caliber, plastic stents can become occluded with the 
development of secondary infection; thus, increasing the need 
for re-intervention and surgical treatment when endoscopic 
re-treatment fails. Moreover, if a necrosectomy is required 
following drainage by plastic stents, the endoscopist must first 
remove the stents and then drive the scope through the drain-
age tract to extract the necrotic material, which often requires 
multiple tract dilations and scope insertions into the PFC and 
increases the risk of procedural morbidity.
To overcome these limitations, fully covered self-expanding 
metal stents (FCSEMSs) and specially designed lumen-ap-
posing metal stents (LAMSs) in which both ends are flared 
have been proposed, with the rationale of providing a large 
opening that would theoretically allow for longer patency, 
reduce rates of stent occlusion and decrease the probability of 
secondary infections, and provide a lasting approach route to 
perform multiple tissue sections via necrosectomy.7,9,13,14 In a 
retrospective cohort study including 230 patients with PFCs, 
especially pancreatic pseudocysts, EUS-guided drainage using 
FCSEMSs improved clinical outcomes (complete resolution of 
pseudocyst, 98% vs. 89%, p=0.01) and reduced adverse event 
rates (16% vs. 31%, p=0.006) compared with plastic stents.15 A 
prospective comparative study demonstrated that EUS-guided 
PFC drainage using a FCSEMS was comparable to that using 
plastic stents regarding technical feasibility, efficacy, and safe-
ty. The median procedure time using a FCSEMS was signifi-
cantly shorter than that using plastic stents (15.0 minutes vs. 
29.5 minutes, p<0.01).16
Recently, endoscopists have seen the development and 
commercial release of specially designed, fully covered, 
transluminal self-expanding metal stents (SEMSs), such as the 
AXIOS (Boston Scientific, Natick, MA, USA) and Nagi (Tae-
woong Medical, Goyang, Korea) stents, which are designed 
with wide flanges on both ends to prevent migration (Fig. 2). 
These devices have a wide diameter (10 to 16 mm) and short 
length, and to some extent, they can actively hold a PFC in the 
lumen. Endoscopic necrosectomy can be performed directly 
through these devices owing to their wider diameter. Large 
cohort studies have demonstrated high technical success rates 
(91% to 98%) and clinical success rates, defined as resolution 
of clinical symptoms with a decrease in PFC size to ≤2 cm on 
imaging (81% to 100%).7,17,18
Few data are available regarding the proper period for 
Literature search
54 Metal stent 9 Therapeutic EUS
1. Original article, systemic review, case series
2. Case number ≥20
3. English language
Fig. 1. Flow diagram of the literature review. EUS, endoscopic ultrasonogra-
phy. 
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stent removal. One prospective, single-center study showed 
the safety and efficacy of short-duration (3 weeks) FCSEMS 
placement for symptomatic pseudocysts, along with selective 
pancreatic ductal stenting in patients with persistent ductal 
leak. During a median follow-up of 306 days, two recurrences 
(4.7%) were detected in 42 patients.19 This study demonstrat-
ed that short-term placement of FCSEMSs with pancreatic 
ductal stenting for the treatment of pseudocysts is safe and 
effective.
FCSEMSs have been used with the hope that a large lu-
minal diameter would facilitate more effective and lasting 
drainage. However, unfortunately, SEMSs may migrate and 
have been reported to cause mucosal injury and bleeding 
from erosion of the opposite wall of the cavity once the PFC 
is resolved. A recent study showed a 26% incidence of late ad-
verse events after FCSEMS placement for PFCs.20 A systematic 
review including 17 studies and 881 patients who underwent 
endoscopic treatment of PFCs using plastic versus biliary 
FCSEMSs did not support routine deployment of metal stents 
for drainage of PFCs, reporting similar pooled success rates 
for metal stents (81.9%) and plastic stents (80.7%) and higher 
pooled complication rates (such as bleeding, secondary infec-
tion and stent migration) with metal stents (23.3%) compared 
with plastic stents (16.1%).21
Several novel LAMSs specially designed for transmural 
drainage allow single-step deployment and effective drain-
age of cystic fluid with minimal stent migration (Table 
1).7,13,14,17,18,22-24 The AXIOS and Nagi stents have high reported 
treatment success rates of 93% to 100%, but these results are 
limited to small studies of 10 to 33 patients. Further random-
ized trials are needed to justify the use of metal stents for PFC 
drainage.
Despite advances in metal stent development and the the-
oretical advantages of metal stents over plastic stents, there is 
no universal agreement as to which type of stent should be 
used for drainage of PFCs. Based on the current literature, 
one stent type cannot be clearly recommended over other 
types for EUS-guided drainage of PFCs. Endoscopists should 
Fig. 2. Lumen-apposing metal stent. (A) AXIOS stent (Boston Scientific), (B) Nagi stent (Taewoong Medical Co. Ltd.). Adapted from Boston Scientific and Taewoong 
Medical Co. Ltd.
A 
B
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choose a stent type they are comfortable using and one that 
they feel is most appropriate for each individual case. The 
AXIOS and Nagi stents may be preferable when necrosecto-
my is required, because the endoscopist can drive the scope 
directly through the stent and into the PFC for removal of 
solid necrotic material.
PANCREATIC DUCT DRAINAGE
The development of interventional EUS has provided an 
alternative means of relieving pancreatic duct obstruction that 
is not possible by ERCP through transpapillary access to the 
pancreatic duct, especially in pancreaticojejunal stenosis or 
pancreaticogastric anastomosis after Whipple resection, which 
can result in recurrent acute pancreatitis, main pancreatic 
duct (MPD) stenosis due to chronic pancreatitis, or post-pan-
creatic damage after failure of ERCP.10 EUS-guided transmural 
stenting using plastic stents was performed in cases in which 
advancing a guidewire across the anastomosis site was impos-
sible, when the major papilla was under complete pancreatic 
obstruction, or when the MPD had a tortuous configuration.25 
However, rates of complications, including bleeding, fever, 
perforation, and hematoma, are typically higher for transmu-
ral stenting than for simple rendezvous placement.26 FCSEMSs 
have not yet been used for EUS pancreatic duct drainage with 
transmural stenting because of concerns regarding stent mi-
gration and a cross-stream blockage of the MPD that covers 
the membrane of the FCSEMS.25 Recently, Oh et al.27 showed 
that EUS pancreatic duct drainage using a FCSEMS may be 
technically feasible and relatively safe without adverse events 
related to FCSEMSs, including stent migration, clogging, 
and stent-induced ductal stricture. In the future, FCSEMSs 
should be further modified with an anti-migration structure 
and appropriate diameter to decrease the risk of branch duct 
blockage, and a well-designed randomized controlled trial is 
also needed.
BILE DUCT DRAINAGE
In cases in which papillotomy and bile duct cannulation are 
not successful, either because of an altered anatomy by previ-
ous gastrointestinal surgery or because of a tight tumor steno-
sis, surgery and/or percutaneous transhepatic biliary drainage 
(PTBD), which have higher morbidity and mortality rates 
than those of ERCP, have been suggested as alternative meth-
ods.28,29 EUS-guided biliary drainage (EUS-BD) is considered 
an effective salvage procedure for failed ERCP in patients 
with unresectable malignant biliary obstruction. In patients 
with malignant distal common bile duct obstruction requiring 
SEMS placement, the short-term composite success defined as 
the ability to complete the intended therapeutic procedure in 
a single session and resulting in a greater than 50% decrease 
in bilirubin over 2 weeks using EUS-BD was reported to be 
comparable to that of ERCP in a retrospective analysis.30
In the early 2000s, a large-channel echoendoscope made 
possible the first reported case of EUS-BD including trans-
gastric or transduodenal biliary drainage, which had been 
initially described for palliative management of malignant 
biliary obstruction.5,6,31 The different access routes (transhepatic 
or extrahepatic), directions of stent insertion (anterograde or 
retrograde), or drainage routes (transluminal or transpapil-
lary) have been controversial, with varying success rates and 
complication rates, for EUS-BD.32 Although no randomized 
trial has directly compared the rendezvous and transluminal 
techniques, both techniques were equally effective and safe 
according to a small retrospective study, and the authors 
concluded that the transluminal approach is a reasonable 
approach secondary to rendezvous EUS-BD, because cumber-
some wire manipulations are not needed.33
A report by a single endoscopist that included 101 patients 
Table 1. Recent Studies of Lumen-Apposing Metal Stents for PFCs Drainage
Study Stent type No. of patients PFC type
PFC size, 
mm TSR, % CSR, % ADR, n (%)
Y amamoto et al. (2013)24 Nagi 9 Pseudocyst/WON 146a) 100 77 Late 2 (22)
C handran et al. (2015)20 Nagi 47 Pseudocyst/WON 100b) 98.1 76.6 10 (21)/14 (29)c)
Walter et al. (2015)17 Axios 61 Pseudocyst/WON 90b) 98 93/81d) 5 (9)
Siddiqui et al. (2015)18 Axios 82 Pseudocyst/WON 118a) 97.5 98.7 4 (28.5)/9 (13.2)d)
Shah et al. (2015)7 Axios 33 Pseudocyst/WON 90a) 91 93 5 (15)
Bapaye et al. (2015)14 Nagi 19 Pseudocyst/WON 107a) 100 100 2 (10.5)
Itoi et al. (2012)13 Axios 15 Pseudocyst 98a) 100 100 1 (6.6)
PFC, pancreatic fluid collection; TSR, technical success rate; CSR, clinical success rate; ADR, adverse reaction rate; WON, walled-off necrosis.
a)Mean; b)Median; c)Early (<24 hours)/delayed (>24 hours) adverse events; d)Pancreatic pseudocyst/wall-of necrosis. 
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showed that the risk of procedure-related death decreases 
with the learning curve, even if EUS-BD is an efficient tech-
nique.34 In connection with this, a newly designed stent intro-
ducer having a fine gauge metal tip and a 7 F shaft diameter 
has been evaluated to enable one-step stent placement without 
a further fistula dilation step, potentially decreasing the risk of 
adverse events by immediately sealing the transmural fistula.25
There are two main approach routes in EUS-BD in terms 
of the organ on which a non-anatomic fistula is connected to 
the biliary tree: EUS-CDS and EUS-HGS. The EUS-HGS and 
EUS-CDS techniques exhibited similar efficacy and safety in 
a single-center randomized trial.35 EUS-CDS has several po-
tential advantages compared with endoscopic transpapillary 
stenting (ETS), including a lower risk of post-procedural pan-
creatitis, lower risk of tumor ingrowth and overgrowth, and 
higher technical success rate.35 A comparative cohort study 
that evaluated the clinical efficacy and safety of EUS-CDS 
and ETS as first-line treatments for malignant distal biliary 
obstruction showed that EUS-CDS was associated with short 
procedure times and no risk of pancreatitis.35
PTBD is the most commonly used alternative drainage 
method for intrahepatic ducts but has a relatively high rate of 
complications and is frequently associated with patient dis-
comfort related to the external drainage.36 The advantage of 
EUS-HGS compared with PTBD is the lower risk of bleeding, 
through the use of color Doppler, which can prevent punc-
turing of intervening vessels.3 However, bile leakage is a po-
tential significant adverse event. In a multicenter retrospective 
analysis, EUS-HGS was related to complications including 
cholangitis, perforation, bile leakage, and bleeding (p=0.031).32 
The left hepatic ducts are easily visualized by EUS; thus, a 
transgastric approach to the left biliary system was initially 
introduced, and hepatic hilar obstruction and isolated right 
intrahepatic duct obstruction are not normal indications for 
EUS-HGS.37 However, recently, sequential deployment of two 
stacked stents was used in isolated right intrahepatic duct ob-
struction to prevent bile leakage from the fistula and bile duct 
branch occlusion using FCSEMs. This method is known as the 
locking-stent method and is performed using an uncovered 
stent initially deployed from the upper common bile duct to 
B, and then a bare-ended, fully covered stent is inserted into 
the first stent from B3 to the stomach.38 For standardization 
of EUS-HGS in cases of failed ERCP, the development of a 
standard protocol for endoscopic procedures and a more spe-
cific and dedicated device for effective and safe deployment of 
metal stents without complications is required.39
As FCSEMSs offer prolonged stent patency (compared 
with plastic stents) and easy stent revision without increasing 
procedural complications such as bile leakage (compared with 
plastic stents or SEMSs), EUS-BD using FCSEMSs was sug-
gested as the ideal option for failed ERCP cases.40,41 In addi-
tion, EUS-BD using the FCSEMS procedure provides a biliary 
transmural drainage route away from a duodenal SEMS and 
thus may be expected to prolong the time to dysfunction of a 
biliary stent compared with transpapillary drainage in cases 
with an indwelling duodenal SEMS.42 FCSEMSs appear to be 
a better option for EUS-BD because with full expansion, it 
effectively seals the puncture tract; thus, preventing leakage, 
and the larger diameter provides better long-term patency. 
Furthermore, in cases of stent occlusion, revision was more 
manageable compared with plastic stents, as a new stent can 
be placed into the occluded metal stent.10 
GALLBLADDER DRAINAGE
Laparoscopic cholecystectomy is the standard approach 
used for patients with acute cholecystitis.43 However, some 
patients are improper for cholecystectomy because of ad-
vanced age, underlying comorbidities, or malignancies. In 
these cases, percutaneous transhepatic gallbladder drainage 
(PTGBD) is the treatment of choice, and shows clinical suc-
cess rates of 56% to 100%.44 Nevertheless, the percutaneous 
approach has many weak points, including bleeding, pneu-
moperitoneum, bile leakage, and catheter dislodgement; 
additionally, long-term percutaneous drainage leads to dis-
comfort in patients. Furthermore, high recurrence rates of 
cholecystitis of up to 41% have been reported after removal 
of the drainage catheter.45,46
Endoscopic methods for gallbladder drainage (GBD) in-
clude the transpapillary approach or EUS-guided transmural 
GBD. Jang et al.47 showed that EUS-GBD is comparable with 
PTGBD in terms of technical feasibility and clinical efficacy 
for the treatment of acute cholecystitis in high-risk surgical 
patients. However, to date, there are a few data on the safety 
and feasibility of EUS-guided transmural GBD, because pre-
vious tubular-shaped stents have risks, such as bile leakage or 
migration. Furthermore, the slow flow of bile and the small 
caliber of plastic stents can result in early malfunction and 
clogging. Thus, a modified FCSEMS, with enlarged flares (22 
mm external diameter) and stents angulated to 90° to prevent 
migration after placement, was suggested to create a safe 
fistula tract connecting the bowel and gallbladder without 
intraperitoneal bile leakage.37 Recently, specifically designed 
LAMSs have been developed for transenteric drainage and 
successfully tested in animal models.39 In a small case series, 
EUS-guided cholecystoenterostomy using a LAMS was found 
to facilitate internal GBD in non-surgical candidates who have 
a percutaneous cholecystostomy catheter.48 However, reports 
on the use of a LAMS for GBD are limited to small case se-
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ries without long-term follow-up.38 Recently, in a multicenter 
prospective study, EUS-GBD using a newly developed LAMS 
device showed promising results (technical success rate, 90%; 
clinical success rate, 96%; stent- or procedure-related mortali-
ty rate, 7%) in high-risk surgical patients with acute cholecys-
titis.49
FUTURE DEVELOPMENT FOR 
GASTROENTEROSTOMY
Surgical gastroenterostomy has been the standard palliative 
therapy for malignant GOO due to stomach, duodenum, or 
pancreatic cancer. Endoscopic placement of an enteric SEMS 
across the malignant stricture is an alternative treatment op-
tion. This procedure leads to recovery of oral intake in ~90% 
of patients; however, it may be complicated by recurrent ob-
struction caused by either stent migration or tumor infiltra-
tion.50 An alternative approach is the creation of EUS-guided 
endoscopic gastroenterostomy using metal stents. Endoscopic 
gastrojejunostomy (GJS) appears to be ideal for malignant 
GOO because of the short length of anastomosis in surgical 
GJS and the less invasive nature of endoscopic metal stent 
placement. Endoscopic GJS is divided into two approaches, 
GJS using flexible forward-view endoscopy and that using an 
echoendoscope.51
LAMSs such as the Spaxus (Taewoong Medical) or AXIOS 
stent have been developed, and EUS has been used to guide 
placement of LAMSs to create gastrogastric fistulas (Fig. 3). 
Itoi et al.52 showed that creation of an EUS-guided GJS using 
a novel enteric balloon and metal stent was promising as a 
minimally invasive treatment in an animal model. This tech-
nique involves utilizing a specially created double-balloon 
enteric tube (Tokyo Medical University type; Create Medic, 
Yokohama, Japan) to stabilize the small bowel adjacent to the 
stomach in the area of the puncture and LAMS placement. A 
prospective study was performed on EUS-guided double-bal-
loon-occluded GJS bypass using LAMSs in 20 patients in 
2015. The technical success rate was 90% (18/20).51,53
We hope that in the near future many patients suffering 
from malignant GOO can benefit from safe endoscopic gas-
troenterostomy using dedicated metal stents, which enable 
both secure anastomosis and passage of food. In addition, 
the prevalence of obesity and diabetes has exponentially 
increased globally, and conventional bariatric surgery is cur-
rently regarded as the only treatment that typically results in 
large, sustained weight losses and diabetes control for patients 
intractable to medical treatments. However, bariatric surgery 
also carries perioperative risks. Therefore there is a great need 
for minimally invasive weight-loss procedures in treatment 
sequence. In this context, we believe that the endoscopic by-
pass procedure using a simple anastomosis method with a 
LAMS has the potential to be a minimal invasive treatment 
strategy for metabolic diseases, including obesity and type 2 
diabetes.54
CONCLUSIONS
Although no established data support EUS-guided trans-
mural drainage of PFC using metal stents over plastic stents, 
metal stents could be considered at the discretion of the phy-
sician, based on operator preference and experience. LAMSs 
should be considered for walled-off necrosis of the pancreas, 
because necrosectomy is possible without laborious compli-
cated procedures and thus reduces the risk of morbidities. 
The development of new stents for various procedures has 
expanded our ability to effectively drain fluids from the pan-
creas and gallbladder, approach the bile duct, and perform 
GJS. Future studies should delineate more clearly which type 
Fig. 3. Lumen-apposing metal stent. Spaxus stent (Taewoong Medical Co. Ltd.). Adapted from Taewoong Medical Co. Ltd.
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of therapeutic procedure using metal stents is best suited to a 
specific disease entity.
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